Loading compound...
DNA disrupting agent and enzyme inhibitor
Bisantrene is a small molecule drug currently being studied in clinical trials. It works by disrupting DNA and inhibiting a specific enzyme called FTO. It is primarily being researched for the treatment of acute myeloid leukemia.
How it worksBisantrene works by interfering with DNA and targeting an enzyme called FTO to help fight cancer cells.
Used for
acute myeloid leukemia
Conditions
acute myeloid leukemia
Class
DNA disrupting agentFTO inhibitorDNA disrupting agent and enzyme inhibitorhematologic
Talk to your doctor
Questions to ask
- ·Is Bisantrene appropriate for my type of leukemia?
- ·What are the potential risks of Bisantrene during clinical trials?
- ·How does Bisantrene target cancer cells?
Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.